Home » Topics » BioWorld Science

BioWorld Science
RSS

Debiopharm and Ubix collaborate to develop antibody degraducer conjugates

June 17, 2021

Topline data from phase I study of NASH drug candidate ASC-42

June 17, 2021

Mydecine launches in silico drug discovery program with University of Alberta

June 17, 2021

DSMB recommends phase I trial of rhenium nanoliposomes in GBM proceed to next cohort

June 17, 2021

Phase I/II trial of eprenetapopt in TP53-mutant AML meets primary efficacy endpoint

June 17, 2021

Safety data presented for BGB-11417 in R/R B-cell malignancies

June 17, 2021

MacroGenics and Zai Lab collaborate on bispecific molecules in immuno-oncology

June 17, 2021

Paratek opens phase IIb study of Nuzyra in M. abscessus pulmonary disease

June 17, 2021

Switching on prodrugs with radiotherapy shows promise

June 17, 2021

Second patient dosed in phase I/II MARVEL-1 study of FLT-190 in Fabry disease

June 17, 2021

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...